It’s scary to think that SAP was ever a most valuable European company. Just imagining this makes my brain bleed.
Edit: I understand the _why_, no concerns about that. SAP plays their role. However everything around SAP is a catastrophic failure when it comes to implementation. Not due to fault of software, some of it is pretty nice, I am sure (especially HANA/4). But business model based on extortion is hard to swallow.
pierperrier on
Wait it is not LVMH?
Econ_Orc on
Really shows how massive influence a USA president and other incidents on the global market influence stock market value.
Danish share owners of Novo Nordisk has seen their stock value decline by 100 billion kroner in one year.
Novo shared data on yet another anti fat drug which caused the the stock value to increase. There is a lot of money to earn on people wanting to loose weight (and maybe not so interested in exercise and moderation of calorie intake over a longer time period)
fpPolar on
Novo Nordisk is down -44% for the year and SAP is up +56% on the year. SAP must have just recently passed them.
Mammoth_Professor833 on
I’m long fat people so this makes sense
teddbe on
Ozempic has really took off
wirtnix_wolf on
Are there companies running SAP and make Profits? Asking for a friend
7 commenti
It’s scary to think that SAP was ever a most valuable European company. Just imagining this makes my brain bleed.
Edit: I understand the _why_, no concerns about that. SAP plays their role. However everything around SAP is a catastrophic failure when it comes to implementation. Not due to fault of software, some of it is pretty nice, I am sure (especially HANA/4). But business model based on extortion is hard to swallow.
Wait it is not LVMH?
Really shows how massive influence a USA president and other incidents on the global market influence stock market value.
Danish share owners of Novo Nordisk has seen their stock value decline by 100 billion kroner in one year.
https://www.macrotrends.net/stocks/charts/NVO/novo-nordisk/stock-price-history
https://www.investtech.com/dk/market.php?CompanyID=45100069
Novo shared data on yet another anti fat drug which caused the the stock value to increase. There is a lot of money to earn on people wanting to loose weight (and maybe not so interested in exercise and moderation of calorie intake over a longer time period)
Novo Nordisk is down -44% for the year and SAP is up +56% on the year. SAP must have just recently passed them.
I’m long fat people so this makes sense
Ozempic has really took off
Are there companies running SAP and make Profits? Asking for a friend